Key Market Indicators
Sales of Italian antihypertensive medications are forecast to drop by 1.3% a year on average to reach $194 million by 2026. Since 2016, demand has decreased by 3% annually. Germany overtook Italy in 2021, reaching $216.81 million. Italy, Spain, and Australia followed in second, third, and fourth place, respectively.
